Public judges GLP-1 weight-loss users harsher, study reveals
A four-study, 1,205-participant analysis across Belgium, the US, and the UK found that users of anti-obesity medications, especially GLP-1 drugs, are judged as exerting less effort and are rated as less moral, warm, and deserving of weight-loss outcomes; perceived effort strongly drives moral judgments, with attitudes toward AOM and prior experience mitigating bias, while viewing AOM as a shortcut amplifies it; researchers urge public education to reduce stigma around obesity treatments.